Evidence map›Paper›PMID 24954098›Full record

ArticleJournal of proteomics2014

Sex differences in the acute in vivo effects of different human SP-A variants on the mouse alveolar macrophage proteome.

David S Phelps, Todd M Umstead, Joanna Floros

Open access · greenAbstract read
In one paragraph

Article in Journal of proteomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David S PhelpsThe Center for Host Defense, Inflammation, and Lung Disease (CHILD) Research, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Todd M UmsteadThe Center for Host Defense, Inflammation, and Lung Disease (CHILD) Research, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Joanna FlorosThe Center for Host Defense, Inflammation, and Lung Disease (CHILD) Research, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA; Department of Obstetrics and Gynecology, The Pennsylvania State University College of Medicine, Hershey, PA, USA. Electronic address: jfloros@psu.edu.
Pennsylvania State University · US

Funding

SURFACTANT PROTEINS AND RESPIRATORY DISTRESS SYNDROMER37HL034788 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI FLOROS, JOANNA · 1996 to 2005
$3.2M
SURFACTANT PROTEINS AND RESPIRATORY DISTRESS SYNDROMER01HL034788 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI FLOROS, JOANNA · 1985 to 2011
$3.0M
OZONE EFFECTS ON FUNCTION OF SURFACTANT PROTEIN VARIANTSR01ES009882 · NIEHS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI FLOROS, JOANNA · 1999 to 2010
$2.5M
NHLBI NIH HHS HL 34788NHLBI NIH HHS R01 HL034788NHLBI NIH HHS R37 HL034788NIEHS NIH HHS R01 ES009882
6 · The paper itself

Abstract

Surfactant protein A (SP-A) is involved in lung innate immunity. Humans have two SP-A genes, SFTPA1 and SFTPA2, each with several variants. We examined the in vivo effects of treatment with specific SP-A variants on the alveolar macrophage (AM) proteome from SP-A knockout (KO) mice. KO mice received either SP-A1, SP-A2, or both. AM were collected and their proteomes examined with 2D-DIGE. We identified 90 proteins and categorized them as related to actin/cytoskeleton, oxidative stress, protease balance/chaperones, regulation of inflammation, and regulatory/developmental processes. SP-A1 and SP-A2 had different effects on the AM proteome and these effects differed between sexes. In males more changes occurred in the oxidative stress, protease/chaperones, and inflammation groups with SP-A2 treatment than with SP-A1. In females most SP-A1-induced changes were in the actin/cytoskeletal and oxidative stress groups. We conclude that after acute SP-A1 and SP-A2 treatment, sex-specific differences were observed in the AM proteomes from KO mice, and that these sex differences differ in response to SP-A1 and SP-A2. Females are more responsive to SP-A1, whereas the gene-specific differences in males were minimal. These observations not only demonstrate the therapeutic potential of exogenous SP-A, but also illustrate sex- and gene-specific differences in the response to it. BIOLOGICAL SIGNIFICANCE: This study shows that changes occur in the alveolar macrophage proteome in response to a single in vivo treatment with exogenous SP-A1 and/or SP-A2. We demonstrate that SP-A1 and SP-A2 have different effects on the AM proteome and that sex differences exist in the response to each SP-A1 and SP-A2 gene product. This study illustrates the potential of exogenous SP-A1 and SP-A2 treatment for the manipulation of macrophage function and indicates that the specific SP-A variant used for treatment may vary with sex and with the cellular functions being modified. The observed changes may contribute to sex differences in the incidence of some lung diseases.

Indexed as

Sex CharacteristicsAcute DiseaseAnimalsCHO CellsCricetinaeCricetulusFemaleHumansInflammationMacrophages, AlveolarMaleMiceMice, KnockoutOxidative StressProteomePulmonary Surfactant-Associated Protein AProteomePulmonary Surfactant-Associated Protein ASFTPA1 protein, humanSFTPA2 protein, humanActinAutophagyInflammationInnate immunityOxidative stressSurfactant

Identifiers

PMID24954098
PMCPMC4128237
OpenAlexW1973697258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.